Leland Gershell

Amarin Corporation plc (NASDAQ: AMRN) shares were tumbling Tuesday in reaction to a negative verdict issued by a U.S. District Court regarding generic versions of its fish oil pill Vascepa. Amarin shares, which rose to 52-week high of $26.12 in mid-December in reaction to a Vascepa...

Recro Pharma Inc (NASDAQ: REPH) shares were crashing Monday in reaction to an adverse regulatory decision on its lead pain medication candidate that was announced late Friday. What Happened Recro, a micro-cap specialty pharma company that focuses on therapeutics for hospitals and other acute care...

Vaccinex Inc (NASDAQ: VCNX) has fallen nearly 17 percent since its Aug. 8 Nasdaq debut, but one analyst anticipates relief from the growing pains. The Analyst Oppenheimer analyst Leland Gershell initiated coverage of Vaccinex with an Outperform rating and $22 price target. The Thesis...